NARAYANA KODURI: Open Payments
NPI 1124279427 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 99 payments from 11 companies in 2025. Trend: 2023 $841 · 2024 $969 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $439 |
| ABBVIE INC. | 26 | $268 |
| E.R. Squibb & Sons, L.L.C. | 16 | $257 |
| Teva Pharmaceuticals USA, Inc. | 14 | $213 |
| Alkermes, Inc. | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Lundbeck LLC | 1 | $18 |
Products named: REXULTI, VRAYLAR, COBENFY, ABILIFY MAINTENA, UZEDY, ARISTADA, AUSTEDO XR, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
